Oct 13, 2022 7:00 am EDT NeoGenomics Schedules its Third Quarter 2022 Earnings Release for November 8, 2022
Sep 7, 2022 2:00 am EDT NeoGenomics and Liquid Biopsy Subsidiary Inivata and Collaborators to Present New Data at ESMO Congress 2022
Aug 16, 2022 5:00 pm EDT NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 15, 2022 4:05 pm EDT NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022
Jun 21, 2022 2:00 am EDT NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer
Jun 3, 2022 4:05 pm EDT NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences
